On Monday, July 10, the next meeting of the Transparency Council.
The agenda includes:
Preparation of an opinion for the amendment of the conditions required for the electrophysiology laboratory under the benefit "Comprehensive care after myocardial infarction".
Preparation of positions on drug evaluation:
- Oramorph (morphini sulfas) for the following indication: treatment of patients with malignant tumors, chronic postherpetic neuralgia,...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
